---All---
  • ---All---
  • Accession
  • Catalog #

Cytokeratin-5 AntibodyRabbit Polyclonal IgG Affinity Purified

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AJ1227a 100ul 400 ul 2-3 days $ 315.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

Cytokeratin-5 Antibody - Product info

ApplicationWB, IHC
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP13647
ReactivityHuman
Clone NamesPolyclonal
Calculated MW62378 Da
Gene ID 3852
Other Names
KRT5, Keratin, type II cytoskeletal 5, 58 kDa cytokeratin
Target/Specificity
A synthetic peptide corresponding to residues near the N-terminus of human CK-5 was used as an immunogen.
Dilution
WB~~1:1000~10000
IHC~~1:50~100
Format
50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
Cytokeratin-5 Antibody is for research use only and not for use in diagnostic or therapeutic procedures.

Cytokeratin-5 Antibody - Protein Information

Name KRT5

Cytokeratin-5 Antibody - Application data

  • A. Western blot analysis on A431 cell lysate of using anti-CK-5 Rabbit Polyclonal (Cat. #AJ1227a), dilution 1:1000

  • B. Immunohistochemical analysis of paraffin-embedded human transitional carcinoma of bladder using anti-CK-5 Rabbit Polyclonal (Cat. #AJ1227a).

Cytokeratin-5 Antibody - Related products

RI12963: KRT5 predesign siRNA

AT2660a: KRT5 Antibody (monoclonal) (M08)

AO1114a: Cytokeratin 5 Antibody

AO1115a: Cytokeratin (Pan) Antibody

AO1256a: Cytokeratin 5 Antibody

AO1269a: Cytokeratin(Pan) Antibody

AJ1227a: Cytokeratin-5 Antibody

AJ1227b: Cytokeratin-5 Antibody

AJ1227c: Cytokeratin-5 Antibody (C-term)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Keratins are cytoplasmic intermediate filament proteins expressed by epithelial cells. The mitotically active basal layers of most stratified squamous epithelia express 10 to 30% of their total protein as keratin. The two keratins specifically expressed in these cells are the type II keratin CK-5 and its corresponding partner, type I keratin CK-14, both of which are essential for the formation of 8-nm filaments (1). CK-5 and calretinin have been useful in different studies as immunohistochemical markers suggestive of mesothelioma, and their expression is analyzed for the histological differential diagnosis with adenocarcinomas, especially when confronting with metastatic tumors of unknown origin (2). Loss-of-function mutations in the keratin 5 gene (KRT5) affected family members and in six unrelated patients with Dowling-Degos disease (DDD), an autosomal dominant genodermatosis. This suggests a crucial role for keratins in the organization of cell adhesion, melanosome uptake, organelle transport, and nuclear anchorage (3).

REFERENCES

1. Lersch R, et al. Mol Cell Biol. 9(9):3685-97, 1989.
2. Cid Mouteira P, et al. Actas Urol Esp 30(4):367-71, 2006.
3. Betz RC, et al. Am J Hum Genet 78(3):510-9, 2006.